RANTES and MCP-3 antagonists bind multiple chemokine receptors
about
Role of the first extracellular loop in the functional activation of CCR2. The first extracellular loop contains distinct domains necessary for both agonist binding and transmembrane signalingDifferential activation of CC chemokine receptors by AOP-RANTESHIV and the chemokine system: 10 years later.The solution structure of the anti-HIV chemokine vMIP-IICCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structureSolution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammationStructure-function relationship between the human chemokine receptor CXCR3 and its ligandsMultimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxisHuman immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes.Control of feeding behavior in C. elegans by human G protein-coupled receptors permits screening for agonist-expressing bacteria.Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitorCCR3 blockade as a new therapy for asthma.The mouse B cell-specific mb-1 gene encodes an immunoreceptor tyrosine-based activation motif (ITAM) protein that may be evolutionarily conserved in diverse species by purifying selection.Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.Chemokines in tumor angiogenesis and metastasisNew therapeutics that modulate chemokine networks.Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse modelBlocking chemokine receptorsRegulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage.HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3.Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivityTruncation of NH2-terminal amino acid residues increases agonistic potency of leukotactin-1 on CC chemokine receptors 1 and 3.Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivityAmino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine.Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: implications for chemotaxis.N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities.Lymphocyte responses to chemokines.Backbone dynamics of the human CC chemokine eotaxin: fast motions, slow motions, and implications for receptor bindingChemokine receptor antagonists: novel therapeutics for inflammation and AIDS.Transcriptional and post-transcriptional regulation of monocyte chemoattractant protein-3 gene expression in human endothelial cells by phorbol ester and cAMP signalling.Chemokines: understanding their role in T-lymphocyte biology.Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium.Gene transfer of RANTES and MCP-1 chemokine antagonists prolongs cardiac allograft survival.
P2860
Q22010723-CE1976E8-F9A8-4DD3-933E-9C674C5A8C40Q22253325-D4A60DE5-0279-42FB-BF38-68BD66703E8EQ27473020-701C23FD-B407-472E-9F75-6806CB2D2C2EQ27620649-27F958F0-A732-4C4E-8B2F-5225AF71B138Q27631819-1682AA75-A5E0-4DB3-8246-9A3B0C6F9570Q27765156-4876CEC6-A1DE-44A9-964E-A7312628C74CQ28213616-0C54CF05-6904-40CC-8C37-7FC5FF2D516BQ28349180-65D0163A-39EA-449F-990A-AB3656D8CB1FQ30938337-90631ECE-8190-40A7-8CD4-98A84AAB8B95Q32159654-EB8ABD6B-EADE-42B8-AF83-1A631FA109DAQ33371683-39E6E478-8C57-4725-A349-E9A6A26A03DAQ33929458-6DB878A4-680D-4713-93E5-AD317E0D5E86Q34074661-88FA518D-4FC8-497F-A7D7-DFF52F68CDB8Q34193922-44061D19-8A1A-4B2F-85E5-E25B42FFC237Q34447967-067CB29F-6951-442C-A950-983521D53639Q34540743-848DF126-8B35-45FD-BF5C-D891DC01B878Q34743328-72F4F8D1-657F-41A6-B666-3CAE4D29F59DQ36150612-B449E0BF-750B-488D-891C-BE96E36DB128Q36380336-5BC0A1E3-AA1A-4837-8998-F1B0F921CD15Q36380770-B1F40C11-C661-4B5B-8C38-0CB0D72E69A9Q36380925-4DA7F5E9-E3CB-4858-90A0-F68015617B05Q36401498-7CC4D8E0-DF5D-4F39-9716-6F1D277D9247Q36419287-A29978D8-877E-4057-9292-38050C80B025Q36616071-20D8C60F-3246-4D16-A9B4-85BC1FB5728AQ38292250-0BB25B70-1F12-4AB0-94C1-5DD4B436216CQ39200573-E6CFE33F-FCAA-47CB-8352-AC376420604EQ39369861-92289721-E777-4D63-9ED3-B4162398E7A1Q39369867-4B06D36B-9448-48D7-ACE6-E50EE4FF14DFQ40584252-976508CA-1F49-42B2-8F91-12165F221E4BQ40795533-6ECEE6A1-2479-4B6B-8456-ECEA3D4BF795Q40852582-8CC91C62-3C5D-43A0-9FFB-8AEC5BE3E15EQ40970857-F70DBA6F-F625-4BCE-A624-369E015566C5Q41014756-353F9127-B3DB-4055-86B5-E416B54F2250Q41722201-D33AEB76-34D2-4672-BBC5-1423900B4BBAQ41776124-1639F9A5-1559-41AC-8F23-5CA4878BB008Q42480705-BBA1E958-EA63-4CAA-9BEA-BA28EE450B78Q42487447-124722F8-08F5-44BA-AD90-2094862326EFQ42991198-5F63EFDA-C17C-421D-A0A0-928F354737BDQ44378760-9C3B91AD-CB0B-4E49-833B-71472E6E172AQ45856772-6D938CA8-E1FE-4415-A282-7659F392A221
P2860
RANTES and MCP-3 antagonists bind multiple chemokine receptors
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@ast
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@en
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@en-gb
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@nl
type
label
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@ast
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@en
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@en-gb
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@nl
prefLabel
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@ast
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@en
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@en-gb
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@nl
P2093
P356
P1476
RANTES and MCP-3 antagonists bind multiple chemokine receptors
@en
P2093
I Clark-Lewis
M Baggiolini
P304
10521-10527
P356
10.1074/JBC.271.18.10521
P407
P577
1996-05-01T00:00:00Z